MediWound (MDWD) Cash & Current Investments (2013 - 2025)
MediWound's (MDWD) quarterly Cash & Current Investments came in at $4.8 million in Q4 2025, down 92.94% year-on-year from $68.0 million in Q4 2024, and down 91.88% quarter-over-quarter from $59.1 million in Q3 2025.
MediWound (MDWD) Cash & Current Investments (2013 - 2025) Analysis & Trends
MediWound's Cash & Current Investments history runs 13 years deep, the most recent figure standing at $4.8 million for Q4 2025.
- On a quarterly basis, Cash & Current Investments fell 92.94% year-over-year to $4.8 million in Q4 2025; TTM through Dec 2025 was $4.8 million, a 92.94% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 92.94% from the prior year.
- Cash & Current Investments retreated to $4.8 million in Q4 2025 per MDWD's latest filing, from $59.1 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $83.0 million in Q2 2023 and bottomed at $4.8 million in Q4 2025.
- The 5-year median for Cash & Current Investments is $36.4 million (2024), against an average of $35.0 million.
- Across the five-year window, Cash & Current Investments surged 393.35% in 2023 and sank 92.94% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $11.0 million in 2021, then surged by 206.85% to $33.9 million in 2022, then increased by 23.05% to $41.7 million in 2023, then jumped by 63.07% to $68.0 million in 2024, then sank by 92.94% to $4.8 million in 2025.
- Per Business Quant, the three latest MDWD Cash & Current Investments figures stand at $4.8 million (Q4 2025), $59.1 million (Q3 2025), and $40.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | MediWound | 165.19 Mn | 160.39 Mn | 278,000.00 | 4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.80 Mn |
| Sep 30, 2025 | 59.09 Mn |
| Jun 30, 2025 | 40.53 Mn |
| Mar 31, 2025 | 38.27 Mn |
| Dec 31, 2024 | 68.01 Mn |
| Sep 30, 2024 | 45.56 Mn |
| Jun 30, 2024 | 37.29 Mn |
| Mar 31, 2024 | 35.57 Mn |
| Dec 31, 2023 | 41.71 Mn |
| Sep 30, 2023 | 45.52 Mn |
| Jun 30, 2023 | 82.98 Mn |
| Mar 31, 2023 | 57.20 Mn |
| Dec 31, 2022 | 33.90 Mn |
| Sep 30, 2022 | 15.07 Mn |
| Jun 30, 2022 | 16.82 Mn |
| Mar 31, 2022 | 16.84 Mn |
| Dec 31, 2021 | 11.05 Mn |
| Sep 30, 2021 | 13.87 Mn |
| Jun 30, 2021 | 17.87 Mn |
| Mar 31, 2021 | 17.86 Mn |